Advertisement

Topics

Companies Related to "Liver Cancer Pipeline Review 2015" [Most Relevant Company Matches] - Page: 4 RSS

10:03 EDT 22nd March 2019 | BioPortfolio

Here are the most relevant search results for "Liver Cancer Pipeline Review 2015" found in our extensive corporate database of over 50,000 company records.

Showing "Liver Cancer Pipeline Review 2015" Companies 76–100 of 3,500+

Relevant

Five Prime Therapeutics

Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases. Five Prime has developed a library of more than 5,600 human extracellular proteins. Five Prime screens this comprehensive library with its proprietary high-throughput protein screening technologies to identify new targets f...


Future Drugs Ltd.

Future Drugs provides healthcare practitioners and research professionals with a unique source of objective cutting-edge information on exciting emerging trends in healthcare and advances in the major therapeutic areas through the Expert Review series. .,Authors are invited to contribute by our Commissioning Editor in liaison with Members of the International Editorial Advisory panels of the Exper...

EASTLAKE DENTAL CARE

Your first appointment gives us a chance to get to know each other. Together, we review your medical and dental history, paying particular attention to your concerns and needs as well as your hopes and desires.Our initial examination is very thorough. We look carefully at your gums, jaw joint, teeth, and muscles, screen for oral cancer, and take x-rays and photographs when needed


Songs For Life

Songs For Life is a new music contest to provide inspiring music for patients to listen to during cancer treatment and to simultaneously fund new cancer research. To enter the Songs For Life contest, artists are asked to submit their original or cover song on www.songsforlife.org between now and November 20, 2014. The top 20 most popular songs as determine...

EPIX Medical Incorporated

Based on its core, proprietary technology, EPIX is advancing its pipeline of products such as MS-325, the Company's lead MRI contrast agent currently in Phase III trials. MS-325 is also in development to help diagnose coronary artery disease, breast cancer, female sexual arousal dysfunction, atherosclerosis and myocardial perfusion. In addition to MS-325, EPIX's pipeline includes a new class of MR...

Alin Foundation

In 1972, Dr. Kenneth N. Matsumura established the Alin Foundation-Corporation primarily as a biotechnology research funding organization. In the 25 years since then, Alin Foundation has helped develop lifesaving treatments for the four diseases -- heart attack, cancer, diabetes, and liver failure -- which combined are responsible for most of the deaths in the United States today. Each of these dev...

Exelixis, Inc.

Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. The company is leveraging its biological expertise and integrated research and development capabilities to generate a pipeline of development compounds with signi...

Can-Fite BioPharma Ltd

CAN-FITE BIOPHARMA LTD is a public company traded on the Tel Aviv Stock Exchange. The Company, which commenced business activity in 2000, was founded by Prof. Pnina Fishman, an investigator from Rabin Medical Center, and patent attorney Dr. Ilan Cohn, a senior partner at Reinhold Cohn Patent Attorneys. Prof. Pnina Fishman serves as the CEO of Can-Fite. The...

Copernicus Group IRB

Copernicus Group IRB was established in July 1996 as an independent institutional review board (IRB or "Board") and operates in compliance with Federal Regulations governing institutional review boards set forth in 21 CFR, 45 CFR and ICH GCP Guidelines. Copernicus Group IRB is also a member of the Consortium of Independent Review Boards (CIRB), which regularly meets with government regulators to r...

CompPartners

CompPartners was the first organization to be nationally accredited by URAC as an external review organization for workers’ compensation. The managed care company leveraged its considerable physician peer-review expertise when it launched SMR (www.specialtymedicalreviews.com) last year. CompPartners was established in 1998, is based in Irvine, Calif.,...

Gritstone Oncology

Gritstone Oncology is a privately-held, next-generation personalized cancer immunotherapy company. Gritstone brings together distinguished scientific founders, an experienced and diverse management team, a seasoned and successful board of directors, and deep financial backing to tackle fundamental challenges at the intersection of cancer genomics, immunolo...

Agilvax

Agilvax discovers and develops targeted cancer immunotherapies and vaccines with its proprietary virus-like particle (VLP) platform technology. Agilvax’s lead product, AX09, is being developed as an immunotherapy for triple-negative breast cancer (TNBC) by targeting cancer stem cells. TNBC has a high frequency of cancer stem cells, which play a critic...

Agilvax, Inc.

Agilvax discovers and develops targeted cancer immunotherapies and vaccines with its proprietary virus-like particle (VLP) platform technology. Agilvax’s lead product, AX09, is being developed as an immunotherapy for triple-negative breast cancer (TNBC) by targeting cancer stem cells. TNBC has a high frequency of cancer stem cells, which play a critic...

Texas Center for Proton Therapy

Texas Center for Proton Therapy is the North Texas region’s first proton therapy center. The center features latest-generation technology, including pencil-beam scanning and image-guided proton therapy, providing precise radiation treatment with the opportunity to reduce side effects. Opening in late 2015, the facility will provide advanced cancer tre...

NAIRO

NAIRO works to promote the value and integrity of the independent medical review process, as an integral part of improving U.S. health care. Its members embrace an evidence-based approach to medical review for resolving coverage disputes between enrollees and their health plans. For more information, visit www.nairo.org.

Gadeta

Founded in 2015, Gadeta has developed a technology platform based on combinatorial T Cell receptor exchange (CTE) to create optimized gamma delta (γδ) T-cell receptors (TCRs) with an enhanced anti-cancer reactivity. Gadeta’s new cell-based anti-cancer product called T Cells Engineered To Express A Defined Gamma Delta TCR (TEGs) has strong therap...

AMDL Incorporated

AMDL develops, manufactures, markets and sells various immunodiagnostic kits, used by laboratories in hospital, clinical, and research settings to obtain precise and rapid identification of certain types of cancer and other diseases. We have two proprietary kits: DR-70® for detection of at least 13 different types of cancer (lung, breast, stomach, liver, colo-rectal, ovarian, esophageal, uterine,...

Prolx Pharmaceuticals LP

PROLX Pharmaceuticals is a privately held biopharmaceutical company dedicated to the discovery of novel target-based therapeutics for the treatment of cancer. PROLX was established to rapidly move novel, proprietary, small molecule pharmaceuticals through pre-clinical development and into clinical trials. Seminal research being conducted by PROLX in collaboration with several leading universitie...

AngioGenex

AngioGenex, Inc., is an emerging, publicly held biopharmaceutical company developing applications based on research into Id genes and proteins... and it is poised to discover the safest, most effective cancer drugs ever made. AngioGenex has: a unique new technology a target validated by a decade of research a pipeline that includes cancer, non-cancer, therapeutic, and diagnostic products AngioGe...

The University of Kansas Hospital

The University of Kansas Hospital is the region's premier academic medical center, providing a full range of care. The hospital is affiliated with the University of Kansas Schools of Medicine, Nursing and Allied Health, and their various leading edge research projects. The constantly growing facility contains 583 staffed beds and serves more than 24,000 inpatients annually. The University of Kansa...

Cancer for College

Cancer for College was formed in 1993 by two-time cancer survivor and double-amputee Craig Pollard. Cancer for College was created to provide hope and inspiration by providing college scholarships to cancer survivors and amputees. Since its inception, Cancer for College has granted nearly $500k in scholarships to more than 400 cancer survivors. For more information about Cancer for College visit w...

Hepregen Corporation

Hepregen Corporation is the undisputed leader in innovating unique and proprietary bioengineered micro- liver platforms for use in environmental testing, preventive care, and pharmaceutical, biotherapeutic and diagnostic product development. The Company’s “liver-in-a-dish” HepatoPac™ and HepatoMune™ products support a potential par...

OmniSeq, LLC

OmniSeq, LLC was established in June 2015 as a for-profit company created from the Center for Personalized Medicine at Roswell Park Cancer Institute (RPCI). OmniSeq offers a suite of innovative products that support a physician-driven, collaborative approach to genomic diagnostics for cancer. The OmniSeqSM Precision Medical Technology platform provides ins...

Transgene SA

Transgene (NYSE-Euronext: TNG), a member of the Institut Mérieux Group, is a biopharmaceutical company. It creates, develops and manufactures targeted immunotherapeutics for the treatment of cancers and infectious diseases. Transgene’s products are major technological breakthroughs. They use well tolerated viruses to indirectly or directly kill infected ...

Axcella Health Inc.

Axcella is designing and developing novel endogenous metabolic modulator compositions to safely reprogram metabolic dysregulation. We are transforming the discovery and development of traditional drug and consumer health candidates from concept to clinical stages, by leveraging our deep understanding of human biology. Our novel approach rapidly gains unpre...


More From BioPortfolio on "Liver Cancer Pipeline Review 2015"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks